Posted by Michael Wonder on 23 Nov 2018
Faster access to groundbreaking medicines as major milestones reached in deal with pharmaceutical industry
23 November 2018 - Cutting-edge and best value drugs will be fast-tracked through the approval process so patients can gain access up to six months earlier.
Patients could have access to new, ground-breaking medicines up to six months earlier and the NHS across the UK is expected to save around £930 million on its medicine bill under a new scheme being finalised with the pharmaceutical industry.
The Government and the Association of the British Pharmaceutical Industry (ABPI) have reached a deal on the Heads of Agreement for a new voluntary scheme for Branded Medicines Pricing and Access, which is expected to come into effect from January 2019.
The final details are still being finalised, but a major milestone has been reached in the discussions which would see the most transformative and best value medicines made available on the NHS more quickly through better horizon scanning, earlier commercial dialogue, and faster appraisals from NICE.
